Pitching accuracy rates of over 99% for multiple cancer screens, Thrive launches with $110 million
For more than 25 years the founders of Thrive Earlier Detection have been...
Tradewind Bioscience attacks the physiology of tumors to treat cancer
Cancer remains the one counterpoint to the march of medical progress that has...